Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
基本信息
- 批准号:8550755
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAgingAlbuminsAllelesAmino AcidsAmino Acids ActivationAutophagocytosisBiogenesisBreedingCalnexinCandidate Disease GeneCategoriesCell LineCellsComplementary DNADiabetes MellitusDiseaseDominant-Negative MutationDown-RegulationEarly EndosomeExcisionFastingGene Expression ProfileGenesGenetically Engineered MouseGolgi ApparatusGrowthGrowth FactorGuanosine Triphosphate PhosphohydrolasesHepatocyteImmunofluorescence ImmunologicImmunoprecipitationInfectionInstitutesLibrariesLiverLysosomesMalignant NeoplasmsMass Spectrum AnalysisMediatingMembraneMembrane Protein TrafficMessenger RNAMolecularMusNull LymphocytesNutrientOrganismPTEN genePathway interactionsPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologyProtein FamilyProtein KinaseProtein Phosphatase 2A Regulatory Subunit PR53Protein phosphataseProteinsProteomicsRNA InterferenceRaptorsRegulationResistanceSeriesSignal PathwaySignal TransductionSirolimusStaining methodStainsStructureSubfamily lentivirinaeSurfaceSystemTSC1/2 geneTechnologyTransgenic MiceTubulinVirusWithdrawalWorkage relatedbasecandidate validationcell growthcostdeprivationdesensitizationembryo cellfallsfeedingfollow-upgenome-widehuman diseaseimmortalized cellimprovedin vivoinhibitor/antagonistknock-downliver infectionmouse modelnovelnovel therapeutic interventionnovel therapeuticsoverexpressionresearch studysmall hairpin RNAstable cell line
项目摘要
DESCRIPTION (provided by applicant): The mechanisms underlying the pro-aging consequences of mTOR activity are obscure. Deregulated mTOR activity leads to accelerated aging and upregulated mTORC1 activity occurs in aging organisms. We recently described the Rag family of proteins as key for mTORC1 activation by amino acids, through a mechanism that requires mTORC1 shuttling to the lysosomal surface. We have generated a series of immortalized cell lines derived from genetically-engineered mice that lack the RagA gene. Although mTORC1 activity is barely detectable in RagA-deficient embryos, cell lines derived from them have reactivated mTORC1 signaling, which is now insensitive to amino acids withdrawal, but sensitive to growth factors withdrawal. Intriguingly, in these lines mTORC1, although active, does not localize to lysosomes, indicating that an additional unknown mechanism of mTORC1 activation is at work. Based on a combination of transcriptional profiling and proteomic-based approaches, we plan to find the genes responsible for the lysosomal-independent activation of mTORC1 and to understand how this occurs. We will then take advantage of RagA-null livers to study in vivo the consequences of altering the expression of the candidates found. Further elucidation of the molecular mechanism leading to mTORC1 desensitization to amino acid withdrawal, together with the identification of druggable targets within this pathway, may pave the way for novel therapeutic approaches to aging and age-related diseases.
描述(由申请人提供):mTOR活性的促衰老后果的潜在机制尚不清楚。失调的mTOR活性导致加速老化,并且在老化生物体中发生上调的mTORC1活性。我们最近描述了Rag蛋白家族作为氨基酸激活mTORC 1的关键,通过一种需要mTORC 1穿梭到溶酶体表面的机制。我们已经产生了一系列的永生化细胞系来自基因工程小鼠,缺乏RagA基因。虽然在RagA缺陷的胚胎中几乎检测不到mTORC1活性,但从它们衍生的细胞系重新激活了mTORC1信号传导,该信号传导现在对氨基酸撤回不敏感,但对生长因子撤回敏感。有趣的是,在这些细胞系中,mTORC1虽然有活性,但并不定位于溶酶体,这表明mTORC1激活的另一种未知机制正在起作用。基于转录谱和蛋白质组学方法的结合,我们计划找到负责mTORC 1的溶酶体独立激活的基因,并了解这是如何发生的。然后,我们将利用RagA缺失的肝脏在体内研究改变所发现候选物表达的后果。进一步阐明mTORC 1对氨基酸戒断脱敏的分子机制,以及确定该途径中的可药物靶点,可能为衰老和年龄相关疾病的新型治疗方法铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Sabatini其他文献
The TORC1 pathway to protein destruction
TORC1 途径导致蛋白质降解
- DOI:
10.1038/nature18919 - 发表时间:
2016-07-27 - 期刊:
- 影响因子:48.500
- 作者:
Lynne Chantranupong;David M. Sabatini - 通讯作者:
David M. Sabatini
Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
氨基酸和 KLHL22 不会通过 DEPDC5 降解来激活 mTORC1
- DOI:
10.1038/s41586-024-07974-0 - 发表时间:
2025-01-08 - 期刊:
- 影响因子:48.500
- 作者:
Max L. Valenstein;Pranav V. Lalgudi;Jibril F. Kedir;Kendall J. Condon;Anna Platzek;Daniel G. Freund;Martin S. Taylor;Yunhan Xu;Raghu R. Chivukula;David M. Sabatini - 通讯作者:
David M. Sabatini
Immunophilins and nervous system
免疫亲和素与神经系统
- DOI:
10.1038/nm0195-32 - 发表时间:
1995-01-01 - 期刊:
- 影响因子:50.000
- 作者:
Solomon H. Snyder;David M. Sabatini - 通讯作者:
David M. Sabatini
Dietary modifications for enhanced cancer therapy
用于增强癌症治疗的饮食调整
- DOI:
10.1038/s41586-020-2124-0 - 发表时间:
2020-03-25 - 期刊:
- 影响因子:48.500
- 作者:
Naama Kanarek;Boryana Petrova;David M. Sabatini - 通讯作者:
David M. Sabatini
MIT Open Access Articles Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
麻省理工学院开放获取文章 Torin2(一种 mTOR、ATM 和 ATR 的 ATP 竞争性抑制剂)的表征
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Qingsong Liu;Chunxiao Xu;Sivapriya Kirubakaran;Xin Zhang;W. Hur;Yan Liu;Nicholas Kwiatkowski;Jinhua Wang;K. Westover;Peng Gao;D. Ercan;M. Niepel;Carson C. Thoreen;S. A. Kang;M. Patricelli;Yuchuan Wang;T. Tupper;Abigail Altabef;Hidemasa Kawamura;Kathryn D Held;Danny M. Chou;Stephen J. Elledge;P. Janne;Kwok;David M. Sabatini;Nathanael S. Gray - 通讯作者:
Nathanael S. Gray
David M. Sabatini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Sabatini', 18)}}的其他基金
Novel Components of the mTORC1 and mTORC2 Pathways
mTORC1 和 mTORC2 通路的新成分
- 批准号:
9042919 - 财政年份:2015
- 资助金额:
$ 23.03万 - 项目类别:
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
- 批准号:
8443550 - 财政年份:2012
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 23.03万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 23.03万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 23.03万 - 项目类别:
Studentship














{{item.name}}会员




